Atazanavir Sulfate

Full Title

Atazanavir Sulfate

Generic Name

Atazanavir Sulfate; Atazanavir and Cobicistat

Chemical Name

...

INV Number

...

Synonym

...

Classification

CAS Number

...

Introduction

Introduction

...

...

Description

...

...

Uses

Uses

...

Treatment of HIV Infection

...

Antiretroviral-naive Adults and Adolescents

...

Clinical Experience

...

Antiretroviral-experienced Adults and Adolescents

...

Clinical Experience

...

Pediatric Patients

...

Clinical Experience

...

Postexposure Prophylaxis following Occupational Exposure to HIV

...

Postexposure Prophylaxis following Nonoccupational Exposure to HIV

...

...

Dosage and Administration

Dosage and Administration

...

Administration

...

Ritonavir-boostedAtazanavir or Unboosted Atazanavir

...

Capsules

...

Oral Powder

...

Cobicistat-boosted Atazanavir

...

Dosage

...

Adult Dosage

...

Treatment of HIV Infection in Antiretroviral-naive Adults

...

Treatment of HIV Infection in Antiretroviral-experienced Adults

...

Postexposure Prophylaxis following Occupational Exposure to HIV

...

Pediatric Dosage

...

Treatment of HIV Infection

...

Table 1: Dosage of Ritonavir-boosted Atazanavir for Pediatric Patients 3 Months of Age or Older Weighing 5 kg or More1 [5]

...

Table 2: Dosage of Ritonavir-boosted Atazanavir for Pediatric Patients 6 Years to Less than 18 Years of Age1 [5]

...

Special Populations

...

Hepatic Impairment

...

Renal Impairment

...

Pregnant and Postpartum Women

...

...

Cautions

Cautions

...

Contraindications

...

Warnings/Precautions

...

Sensitivity Reactions

...

Dermatologic Reactions

...

Cardiovascular Effects

...

Renal Effects

...

Hyperbilirubinemia

...

Phenylketonuria

...

Hepatic Effects

...

Nephrolithiasis and Cholelithiasis

...

Interactions

...

Hyperglycemic and Diabetogenic Effects

...

Immune Reconstitution Syndrome

...

Adipogenic Effects

...

Hemophilia A and B

...

HIV Resistance

...

Specific Populations

...

Pregnancy

...

Lactation

...

Pediatric Use

...

Geriatric Use

...

Hepatic Impairment

...

Renal Impairment

...

Common Adverse Effects

...

...

Drug Interactions

Drug Interactions

...

Drugs Affecting or Metabolized by Hepatic Microsomal Enzymes

...

Drugs Metabolized by Uridine diphosphate-glucuronosyltransferase 1A1

...

Drugs Affected by P-glycoprotein Transport

...

Drugs Affecting or Affected by Other Membrane Transporters

...

Drugs Affecting Gastric pH

...

Acetaminophen

...

Alfuzosin

...

Antiarrhythmic Agents

...

Amiodarone

...

Dronedarone

...

Anticoagulants

...

Apixaban

...

Dabigatran

...

Edoxaban

...

Rivaroxaban

...

Warfarin

...

Anticonvulsants

...

Carbamazepine

...

Eslicarbazepine

...

Ethosuximide

...

Lamotrigine

...

Oxcarbazepine

...

Phenobarbital and Phenytoin

...

Antifungal Agents

...

Fluconazole

...

Isavuconazonium

...

Itraconazole

...

Ketoconazole

...

Posaconazole

...

Voriconazole

...

Antimalarial Agents

...

Atovaquone and Proguanil

...

Antimycobacterial Agents

...

Bedaquiline

...

Rifabutin

...

Rifampin

...

Rifapentine

...

Antineoplastic Agents

...

Dasatinib or Nilotinib

...

Irinotecan

...

Paclitaxel

...

Vinblastine or Vincristine

...

Antipsychotic Agents

...

Lurasidone

...

Perphenazine, Risperidone, Thioridazine

...

Pimozide

...

Quetiapine

...

Antiretroviral Agents

...

HIV Entry and Fusion Inhibitors

...

Enfuvirtide

...

Maraviroc

...

HIV Integrase Inhibitors (INSTIs)

...

Dolutegravir

...

Elvitegravir

...

Raltegravir

...

HIV Nonnucleoside Reverse Transcriptase Inhibitors (NNRTIs)

...

Efavirenz

...

Etravirine

...

Nevirapine

...

Rilpivirine

...

HIV Nucleoside and Nucleotide Reverse Transcriptase Inhibitors (NRTIs)

...

Didanosine

...

Lamivudine and Zidovudine

...

Tenofovir Alafenamide Fumarate

...

Tenofovir Disoproxil Fumarate

...

HIV Protease Inhibitors (PIs)

...

Darunavir

...

Fosamprenavir

...

Indinavir

...

Lopinavir

...

Ritonavir

...

Saquinavir

...

Tipranavir

...

Atovaquone

...

Benzodiazepines

...

Alprazolam

...

Clonazepam

...

Diazepam

...

Midazolam or Triazolam

...

β-Adrenergic Blocking Agents

...

Bosentan

...

Buspirone

...

Calcium-channel Blocking Agents

...

Cobicistat

...

Colchicine

...

Corticosteroids

...

Orally Inhaled or Intranasal Corticosteroids

...

Local Injections of Corticosteroids

...

Systemic Corticosteroids

...

Co-trimoxazole

...

Dapsone

...

Digoxin

...

Eplerenone

...

Ergot Alkaloids

...

Estrogens and Progestins

...

Flibanserin

...

GI Drugs

...

Antacids

...

Cisapride

...

Histamine H2-receptor Antagonists

...

Proton-pump Inhibitors

...

HCV Antivirals

...

HCV Polymerase Inhibitors

...

Dasabuvir

...

Sofosbuvir

...

Sofosbuvir and Velpatasvir

...

HCV Protease Inhibitors

...

Paritaprevir

...

Simeprevir

...

HCV Replication Complex Inhibitors

...

Daclatasvir

...

Elbasvir and Grazoprevir

...

Ledipasvir and Sofosbuvir

...

Atazanavir

...

Ombitasvir

...

HMG-CoA Reductase Inhibitors

...

Atorvastatin

...

Fluvastatin

...

Lovastatin

...

Pitavastatin

...

Rosuvastatin

...

Simvastatin

...

Immunosuppressive Agents

...

Ivabradine

...

Macrolides

...

Azithromycin

...

Clarithromycin

...

Erythromycin

...

Telithromycin

...

Opiate Agonists, Opiate Partial Agonists, and Opiate Antagonists

...

Buprenorphine

...

Fentanyl

...

Methadone

...

Tramadol

...

Phosphodiesterase Type 5 Inhibitors

...

Avanafil

...

Sildenafil

...

Tadalafil

...

Vardenafil

...

Ranolazine

...

Repaglinide

...

St. John’s Wort

...

Salmeterol

...

Selective Serotonin-reuptake Inhibitors

...

Suvorexant

...

Ticagrelor

...

Trazodone

...

Tricyclic Antidepressants

...

Vorapaxar

...

Zolpidem

...

...

Pharmacokinetics

Pharmacokinetics

...

Absorption

...

Bioavailability

...

Food

...

Plasma Concentrations

...

Distribution

...

Extent

...

Plasma Protein Binding

...

Elimination

...

Metabolism

...

Elimination Route

...

Half-life

...

Special Populations

...

...

Advice to Patients

Advice to Patients

...

...

Preparations

Preparations

...

Atazanavir Sulfate

...

Atazanavir Sulfate Combinations

...

...

Common general statement Elements

Additional Information

...

...

References

References

...

...

Copyright

AHFS® Drug Information. © Copyright, 1959-2020, Selected Revisions May 22, 2017. American Society of Health-System Pharmacists, Inc., 4500 East-West Highway, Suite 900, Bethesda, Maryland 20814.

† Use is not currently included in the labeling approved by the US Food and Drug Administration.

Quelle

AHFS Drug Information
Links auf dieser Seite:
  1. https://www.drugbase.de/de/datenbanken/ahfs-drug-information/classification.html?tx_crondavdbahfs_pi%5Bcategory%5D=11&cHash=ded7d770d45852a692316fa0d1373d03
  2. https://www.drugbase.de/de/datenbanken/ahfs-drug-information/classification.html?tx_crondavdbahfs_pi%5Bcategory%5D=63&cHash=868b5a32745c454bb8f5ab864cfad6c0
  3. https://www.drugbase.de/de/datenbanken/ahfs-drug-information/classification.html?tx_crondavdbahfs_pi%5Bcategory%5D=65&cHash=11b8b599ac22eb295c378a5e8cb15f73
  4. https://www.drugbase.de/de/datenbanken/ahfs-drug-information/classification.html?tx_crondavdbahfs_pi%5Bcategory%5D=67&cHash=e42b8720c7a7d8b4ee94b47d0ac2c5ec
  5. https://www.drugbase.de/#ref1